What is the impact of insourcing NGS on patient care?

December 17, 2024

Nikoletta Sidiropoulos, MD describes how insourcing next generation sequencing (NGS) improved patient care at her Institution. Nikoletta Sidiropoulos is an associate professor at the Department of Pathology and Laboratory Medicine, University of Vermont Medical Center. Learn about in-house comprehensive genomic profiling (CGP): https://youtu.be/NErI9YCGcn4?si=ZLZ29OAM4KJUuwtw Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc #Illumina #NGS #biomarker #PrecisionMedicine

Share this article on